Atlas Trials

Study Of the Safety of Locally Manufactured 123I-metaiodobenzylguanidine(MIBG) in Routine Clinical Use

Clinical trial NCT01912040 · WITHDRAWN

Trial details

NCT number
NCT01912040
Sponsor
Nova Scotia Health Authority
Status
WITHDRAWN
Study type
OBSERVATIONAL
Adrenergic Pathology
Start date
2006-07-01
Primary completion
2018-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.